Enhanced activity of human serotonin transporter variants associated with autism.
about
Emerging pharmacotherapies for neurodevelopmental disordersClinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatmentsTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesSerotonin transporter variant drives preventable gastrointestinal abnormalities in development and function.The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter traffickingThe serotonin system in autism spectrum disorder: From biomarker to animal modelsThe Development of Screening Methods to Identify Drugs to Limit ER Stress Using Wild-type and Mutant Serotonin TransporterBehavioural phenotyping assays for mouse models of autismAutism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior.The serotonergic system: its role in pathogenesis and early developmental treatment of autism.Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in miceAn autism-associated serotonin transporter variant disrupts multisensory processing.Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorderHot topics in gut microbiotaTransmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine.Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic RelevanceKinase-dependent Regulation of Monoamine Neurotransmitter Transporters.Rotating disk electrode voltammetric measurements of serotonin transporter kinetics in synaptosomes.Estrogens of multiple classes and their role in mental health disease mechanisms.Regulation of monoamine transporters: Role of transporter phosphorylation.SLC6 transporters: structure, function, regulation, disease association and therapeuticsOntogeny and regulation of the serotonin transporter: providing insights into human disorders.The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasisColocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors.Identification of a novel selective serotonin reuptake inhibitor by coupling monoamine transporter-based virtual screening and rational molecular hybridizationAssociation of Serotonin Transporter Promoter Polymorphism (5HTTLPR) with Microscopic Colitis and Ulcerative Colitis: Time to Be AsSERTive?Oxytocin receptor and Mecp2 308/Y knockout mice exhibit altered expression of autism-related social behaviors.Single molecule analysis of serotonin transporter regulation using antagonist-conjugated quantum dots reveals restricted, p38 MAPK-dependent mobilization underlying uptake activation.A Serotonin Circuit Acts as an Environmental Sensor to Mediate Midline Axon Crossing through EphrinB2.Physical Interactions and Functional Relationships of Neuroligin 2 and Midbrain Serotonin Transporters.Control of serotonin transporter phosphorylation by conformational state.Trophoblast inclusions are significantly increased in the placentas of children in families at risk for autism.Upregulation of serotonin transporter by alcohol in human dendritic cells: possible implication in neuroimmune deregulation.cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake.A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders.Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse.Natural and engineered coding variation in antidepressant-sensitive serotonin transporters.Vesicular and plasma membrane transporters for neurotransmitters.Neuron membrane trafficking and protein kinases involved in autism and ADHD.
P2860
Q24619170-8F7BA24F-2DD3-4610-A323-3382665B924CQ26748761-A50D0636-0A31-486A-93BB-8F6E8BFBE225Q26850307-F07B7509-8939-4DC6-AC88-BEEACD51E9BEQ27023257-984E0DF4-2E84-4CC0-8650-F7123279329DQ27329816-634D1B7F-8FA9-4693-8FB1-2B3222F4CDF6Q28115330-23BD5A27-472B-40AA-8EFF-7E6601D3B82DQ28391614-F42A595F-6D2B-4B02-8A5A-6B0718B991B4Q28818314-731E12D5-7FA0-4556-81E2-2BA7BD00CEF1Q29618414-A89AD05E-8617-49EB-B5ED-90B4CF75BF16Q30462749-6BA15619-E8AF-4BDD-822A-B68D7F88201BQ30484882-F0634619-39E5-4793-BA0E-007B99C37227Q30558687-9E34B299-0E9C-4156-A52E-64B82DDE1882Q30847742-9DA86568-661A-43F8-8618-B6D304BB4B18Q33571104-D0632072-BCAA-4432-89A2-BBDE54CE7270Q33695477-C9C407F1-41AC-4EFB-9C23-26E135AC8A2FQ33799683-F28E50CD-5098-4532-A2B3-D94918E48501Q33926234-B9412577-AF50-4105-B4F5-D54A3D4B9220Q34161514-5C2C32E2-8F2F-41D5-98A2-F016FC4F4EE4Q34188761-09911350-305A-4A9E-A752-39E155541947Q34272184-53C3054F-868B-493F-A377-3D48920F1E4BQ34540543-1F335923-C503-41A4-9C8B-B0C3DB5399F2Q34649517-0D5FAC4B-5633-4269-9A58-0A1D1C8B0A2DQ35090255-C9E3B07A-D8DC-4C78-9645-5F8F19F0ECA2Q35098779-08FA982C-36CE-45E6-A2A9-1DCB8F23B39DQ35188098-A85616C1-3025-45B9-958D-E461181120D6Q35234897-7E86A9BB-7C78-43FB-9554-C516B7A6E3FCQ35694154-021D8DDC-468A-4C8B-8AE8-69F411589C8AQ36055282-D0192508-9690-49AF-A44A-C30C93EDD8D5Q36186670-BDB40BF2-5E6A-45F0-978C-18974DE16836Q36254063-E24C5A0F-4793-4653-AAA3-8ADFB24C8BC1Q36448230-5EDC1BA7-220E-452F-9733-047809987528Q36930972-E0FBC679-4B40-439F-AFA6-401D372B9AEDQ37126976-BF51B941-632A-423B-8CF0-20447CBB5DFDQ37151264-FD3B8837-6BB7-4B69-87A5-7DB2AAA19387Q37318023-7A36F127-9FDF-4626-8962-C3B9ED8A0C26Q37366340-091A01C7-0505-40D4-9D54-2963E2586173Q37449787-6E3ECC80-7BF5-4241-9D2B-FAE1A2168808Q37926644-2EA8EDB4-0DEF-4508-BFA0-978C56CCAE7EQ37971367-2A47C79B-18B6-420E-9E3E-E7A13BEAF21CQ38342576-8CC9D349-1B09-4FD8-A17C-8C9A2F55940E
P2860
Enhanced activity of human serotonin transporter variants associated with autism.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhanced activity of human serotonin transporter variants associated with autism.
@en
Enhanced activity of human serotonin transporter variants associated with autism.
@nl
type
label
Enhanced activity of human serotonin transporter variants associated with autism.
@en
Enhanced activity of human serotonin transporter variants associated with autism.
@nl
prefLabel
Enhanced activity of human serotonin transporter variants associated with autism.
@en
Enhanced activity of human serotonin transporter variants associated with autism.
@nl
P2093
P2860
P356
P1476
Enhanced activity of human serotonin transporter variants associated with autism.
@en
P2093
Harish C Prasad
Jennifer A Steiner
Randy D Blakely
P2860
P304
P356
10.1098/RSTB.2008.0143
P407
P577
2009-01-01T00:00:00Z